Benita Busz-Papież

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone

James E. Udelson, Camille A. Pearte, Carey Kimmelstiel et al. · American Heart Journal · 2011 · 42 citations · Full text

Percutaneous Coronary Intervention, Cardiovascular Disease, Medicine +12

Moderated Posters session IV: Viability and recovery of systolic function. The echo approach * Friday 10 December 2010, 15:30-16:30

Håvard Dalen, Anders Thorstensen, P. R. Romundstad et al. · European Journal of Echocardiography · 2010 · 23 citations · Full text

December 2010, Cardiopulmonary Resuscitation, Posters Session Iv +9

Impact of Left Ventricular Ejection Fraction on Clinical Outcomes Over Five Years After Infarct-Related Coronary Artery Recanalization (from the Occluded Artery Trial [OAT])

Mariusz Kruk, Christopher E. Buller, James E. Tcheng et al. · The American Journal of Cardiology · 2009 · 12 citations

Percutaneous Coronary Intervention, Heart Failure, Endovascular Technique +9